October is Breast Cancer Awareness Month, and most conversations focus on genetics, mammograms, and treatment advances. But there’s a blind spot: toxicology. Everyday exposures—from endocrine-disrupting chemicals in plastics to drug-induced toxicities during treatment—can shape both breast cancer risk and recovery.
If you’re a clinician, researcher, or public health leader, here’s the clear idea: you can’t talk about breast cancer prevention or survivorship without talking about toxicology.
